Recent studies have indicated that BM-derived MSCs (BM-MSCs) could potentially exert anti-diabetic effects in a HFD/STZ rat model of T2DM that resulted in the recovery of pancreatic islets, increased insulin secretion, the correction of hyperglycemia, and ameliorated insulin sensitivity [19,20,21,22]. This evidence concerns the gene INS and Hyperglycemia.